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Washington University School of Medicine, St. Louis, Missouri 63110
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14-3-3 family members are intracellular dimeric phosphoserine-binding proteins that regulate signal transduc-
tion, cell cycle, apoptotic, andmetabolic cascades. Previous work with global 14-3-3 protein inhibitors suggested that
these proteins play a critical role in antagonizing apoptotic cell death in response to provocative stimuli. To
determine the specific role of one family member in apoptosis, mice were generated with targeted disruption of the
14-3-3 gene. 14-3-3/mice did not survive embryonic development, but haploinsufficient mice appeared normal
at birth and were fertile. Cultured adult cardiomyocytes derived from 14-3-3/ mice were sensitized to apoptosis
in response to hydrogen peroxide or UV irradiation. 14-3-3/ mice were intolerant of experimental myocardial
infarction and developed pathological ventricular remodeling with increased cardiomyocyte apoptosis. ASK1, c-jun
NH2-terminal kinase, and p38 mitogen-activated protein kinase (MAPK) activation was increased, but extracellular
signal-regulated kinase MAPK activation was reduced, in 14-3-3/ cardiac tissue. Inhibition of p38 MAPK
increased survival in 14-3-3/ mice subjected to myocardial infarction. These results demonstrate that 14-3-3
plays a critical antiapoptotic function in cardiomyocytes and that therapeutic agents that increase 14-3-3 activity
may be beneficial to patients with myocardial infarction.
The 14-3-3 family of intracellular phosphoserine-binding
proteins regulates many aspects of cell physiology. Initially
identified as abundant brain proteins in 1967, 14-3-3 proteins
are now recognized as critical regulators of signal transduction
cascades, cell cycle checkpoint pathways, apoptotic cascades,
and cell metabolism (5, 13). There are seven mammalian iso-
forms: , , ε, , , /, and , and they all have broad expres-
sion patterns. All 14-3-3 family members bind to phospho-
serine-containing motifs, including the RSXSXP motif and
RXY/FXSXP motifs, where X is any amino acid (14, 23).
14-3-3 proteins are obligate dimers in cells, and both homo-
and heterodimers are formed. The 14-3-3 dimer is able to
simultaneously bind to two phosphoserine-containing motifs
and therefore may have both scaffolding and adapter functions.
Although many binding partners of 14-3-3 proteins have
been identified, a primary function of 14-3-3 proteins may be to
block apoptotic pathways. In previous work, we demonstrated
that global inhibition of 14-3-3 function, by use of dominant-
negative forms of 14-3-3 and 14-3-3 that can inhibit the
activity of all family members, dramatically lowered the apop-
totic threshold of cultured cells or the murine heart (11, 22).
Indeed, cardiac-specific expression of dominant-negative 14-
3-3 in transgenic mice markedly sensitized those animals to
cardiac apoptosis in response to pressure overload by aortic
banding (22). In addition, knockdown of 14-3-3 or 14-3-3ε in
Xenopus laevis embryos sensitized embryonic cells to apoptotic
stimuli (7, 12).
The mechanisms by which 14-3-3 proteins antagonize apop-
tosis are not completely known, but they include the inhibition
of apoptosis signal-regulating kinase 1 (ASK1), a serine/threo-
nine kinase that is activated by tumor necrosis factor alpha,
cytokines, hydrogen peroxide, chemotherapeutic agents, and
endoplasmic reticulum stress (6, 25). Interestingly, hydrogen
peroxide treatment of cultured cells was recently found to
result in dephosphorylation of serine-967 of ASK1, which led
to dissociation of 14-3-3 from ASK1 with resultant ASK1 ki-
nase activation (6). ASK1 activates both the p38 mitogen-
activated protein kinase (MAPK) and the c-jun NH2-terminal
kinase (JNK) cascades. In addition, 14-3-3 proteins antagonize
apoptosis by binding to the BH3 domain-containing protein
BAD and the proapoptotic Forkhead transcription factor
FoxO3a/FKHRL1 (1, 24). JNK activation antagonizes 14-3-3
in the regulation of cell survival in at least two ways: first, via
phosphorylation of BAD at Ser-128, which inhibits its binding
to 14-3-3 (4); second, by direct inactivation of 14-3-3 proteins
by phosphorylation of Ser-184 of 14-3-3, Ser-186 of 14-3-3,
and Ser-184 of 14-3-3 (20).
All seven 14-3-3 family members are expressed in heart
tissue, but our results with frog embryos encouraged us to
determine whether specific knockdown of one family member,
14-3-3, might sensitize tissues to apoptotic stimuli. In this
work we investigated mice with targeted disruption of the 14-
3-3 gene.
MATERIALS AND METHODS
Targeted disruption of the 14-3-3 gene. One allele of the 14-3-3 gene was
disrupted in murine 129/Ola stem cells by BayGenomics (grant U01 HL6662;
http://baygenomics.ucsf.edu). In their method, gene trap vectors were electropo-
rated into 129/Ola embryonic stem cells. Rapid-amplification-of-cDNA-ends
PCR was used to identify the gene that is likely to be disrupted by the gene trap
* Corresponding author. Mailing address: Center for Cardiovascular
Research, Washington University School of Medicine, Box 8086, 660
South Euclid Ave., St. Louis, MO 63110. Phone: (314) 747-3525. Fax:
(314) 747-3545. E-mail: amuslin@im.wustl.edu.
 Published ahead of print on 4 December 2006.
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vector. Genes targeted were entered into the BayGenomics database, and cor-
responding cell lines were stored at 	80°C.
Targeted embryonic stem (ES) cells were thawed and passed for 6 days in ES
cell medium in the absence of G418. Blastocysts were flushed from pregnant
C57BL/6 females (Jackson Laboratory), expanded for 1 to 2 h in ES cell medium,
transferred to a hanging drop chamber, and cooled to 4°C. ES cells were added
to the hanging drops, and the blastocysts were injected with enough cells (20 or
more) to fill the blastocoele. Injected blastocysts were then transferred to pseu-
dopregnant recipient females (10 to 15 blastocysts/uterine horn). Offspring were
bred with C57BL/6 mice, and agouti offspring were bred back into the C57BL/6
genetic background.
Protein analysis. Cytosolic extracts of ventricular tissue or cultured adult
murine cardiomyocytes were separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE), and proteins were electrophoreti-
cally transferred to nitrocellulose filters that were blocked with milk, washed,
and then incubated with primary antibody. Primary antibodies against 14-3-3
were obtained from Santa Cruz Biotechnology (sc-732) and Biosource
(AHZ0542). Other primary antibodies employed were acquired from Cell
Signaling Incorporated: anti-phospho-p38 MAPK (no. 9211), anti-cleaved
caspase-3 (no. 9665), anti-phospho-Akt (no. 9275), anti-Akt (no. 9272), anti-
phospho-JNK (no. 9251), anti-JNK (no. 9252), anti-phospho-extracellular
signal-regulated kinase (ERK) (no. 9101), and anti-ERK1/2 (no. 9102). Fil-
A B
FIG. 1. 14-3-3	/	 animals do not survive embryonic development. A. Male and female 14-3-3/	 animals were mated, and embryonic
offspring were analyzed for genotype by PCR at specific time points after fertilization. B. 14-3-3	/	 embryos die by embryonic day 14. Genetic
analysis of embryos obtained from 14-3-3/	 
 14-3-3/	 matings at various embryonic stages. C. Deciduae containing 14-3-3	/	 embryos are
smaller than heterozygous deciduae. Deciduae from 14-3-3/	 
 14-3-3/	 matings were isolated from adult females at 8 and 11 dpc. In several
cases at 11 or 12 dpc, deciduae containing 14-3-3	/	 embryos were partially resorbed or were dead (see bottom right panel). D. 14-3-3	/	
embryos are hypomorphic and exhibit developmental delay at 9 and 10 dpc. Embryos were carefully dissected from deciduae and were
photographed under a dissecting microscope. Embryos were placed in formalin and were again imaged. E. Cardiac development is delayed but is
otherwise normal in 14-3-3	/	 embryos. Formalin-fixed embryos were embedded in paraffin, sectioned with a microtome, and stained with
hematoxylin and eosin. A transverse section of a paraffin-embedded 9-dpc 14-3-3	/	 embryo is depicted in the figure. Am, amnion; En,
endocardium; FG, foregut diverticulum; Myo, myocardial layer of ventricle; NF, neural folds.
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ters were extensively washed with 1
 Tris-buffered saline–Tween 20 and then
were incubated with alkaline phosphatase-conjugated or horseradish perox-
idase-conjugated secondary antibodies (Amersham). Bands were visualized
with 5-bromo-4-chloro-3-indolylphosphate–Nitro Blue Tetrazolium dissolved
in AP buffer or the ECL system (Amersham). Selected bands on scanned
immunoblots were quantified by the densitometry computer program Image
J (NIH). The target band densities were normalized to the amount of protein
loaded in each lane (i.e., total ERK).
FIG. 1—Continued.
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Adult mouse cardiomyocyte cultures. Primary adult mouse cardiomyocyte
cultures were prepared according to published Alliance for Cell Signaling pro-
tocols (18). Briefly, 8- to 12-week-old lettermates were sacrificed, and their
hearts were cannulated on a 16-gauge needle. Collagenase (1 mg/ml) maintained
at 37°C was circulated through the coronary arterial system for 20 min. Hearts
were minced, and dissolved calcium was introduced into the medium. Cardio-
myocytes were plated onto laminin-coated tissue culture vessels and serum de-
prived (minimal essential medium–Hanks’ buffered salt solution containing 10
mM 2,3-butanedione monoxime, 0.55 g/ml transferrin, and 0.5 ng/ml selenium)
prior to experimentation.
For UVC irradiation studies, after a 4-h or overnight serum deprivation, cells
were irradiated with 180 J/m2 UVC (UV Stratalinker 2400; Stratagene). Irradi-
ated cells were incubated for 12 or 24 h and then harvested. For H2O2 stimula-
tion studies, cardiomyocytes were serum starved for 4 to 12 h, treated with 10 M
H2O2 for 12 h, and then harvested.
Experimental myocardial infarction. Myocardial infarction surgery was per-
formed as previously described (3, 17). In brief, anesthetized and ventilated
12-week-old mice were subjected to thoracotomy. A single 8-0 prolene suture
was tied around the proximal left coronary artery (17). Successful occlusion was
confirmed by the appearance of pallor of the anterior wall of the left ventricle.
The incision was closed, and the animal was allowed to recover on a heating pad.
The surgeon was blinded to the genotype of the mice in every case. After 1 or 7
days, animals were subjected to transthoracic echocardiography. After 7 days,
animals were killed and the hearts were dissected and weighed.
Treatment of mice with SB202190. Mice between 8 and 12 weeks old were
injected with SB202190, a p38 MAPK inhibitor, at a dose of 5 mg/kg of body
weight/day. SB202190 was dissolved in 50% dimethyl sulfoxide with water. Con-
trol vehicle injection was performed by injection of a 50% dimethyl sulfoxide
water solution. On day 4 of SB202190 injection, mice were subjected to myocar-
dial infarction by the method described above. Survival was recorded for the next
5 days. After 5 days the mice were euthanized, and hearts were excised for
histological analysis.
Transthoracic echocardiography. Transthoracic echocardiography was per-
formed with mice that were awake by use of the Acuson Sequoia 256 echocar-
diography system equipped with a 15-MHz (15L8) transducer as described pre-
viously (Acuson) (17). The echocardiographer was blinded in all cases to the
genotype of the mice.
Histological analysis. Murine embryos or adult hearts were fixed in 10%
formalin in phosphate-buffered saline, embedded in paraffin, and sectioned with
a microtome. Hematoxylin and eosin or Masson’s trichrome was used to stain
paraffin sections.
TUNEL. Animals were euthanized, and hearts were excised and fixed over-
night at room temperature in 10% formalin in phosphate-buffered saline, em-
bedded in paraffin, and sectioned with a microtome. The terminal deoxynucle-
otidyltransferase nicked-end labeling (TUNEL) assay was performed on 10-m
sections (TdT-FragEL DNA fragmentation detection kit; Oncogene, Cambridge,
MA). Sections were mounted on coverslips by Permount (Fisher) and evaluated
by colorimetric or fluorescence microscopy.
Analysis of murine embryos. Embryos were isolated from pregnant females by
the method described by Liu et al. (9). Cages were set up with 14-3-3/	 

14-3-3/	 mating pairs. Pregnant mice were euthanized by CO2 asphyxiation at
various times after mating. Entire conceptuses and placentae were isolated
between 7 days postcoitum (dpc) and 17 dpc from pregnant females and pho-
tographed. A portion of the yolk sac or embryo was used to generate chromo-
somal DNA for genotyping by PCR. The embryos and placentae were fixed in
10% formalin in phosphate-buffered saline for histological analyses.
Statistical analysis. All data are reported as means  standard errors of the
means. Statistical analysis was performed by a two-tailed Student t test, analysis
of variance, and the Kaplan-Meier log-rank test, where applicable. A P value
of 0.05 was considered to be statistically significant.
RESULTS
Targeted disruption of 14-3-3. Inspection of the Bay
Genomics web site (http://baygenomics.ucsf.edu) revealed that
a murine embryonic 129/Ola stem cell line had been generated
with disruption of the 14-3-3 genomic locus. This cell line was
subsequently expanded, and targeted stem cells were injected
into C57Bl/6J blastocysts and then placed in pseudopregnant
females. Chimeric offspring were bred with C57BL/6J mice,
and this demonstrated that germ line transmission had oc-
curred in one chimeric mouse. Insertion of the gene trap vector
into the 14-3-3 gene was confirmed by DNA sequencing of a
PCR product derived from murine genomic DNA (data not
shown).
Interbreeding of 14-3-3/	 offspring was performed, but
live-born 14-3-3	/	 mice were never identified by tail-prepa-
ration DNA PCR analysis (Fig. 1A). To determine the stage at
which 14-3-3	/	 embryos died, embryos from heterozygote
breeding pairs were obtained at various gestational ages. DNA
was obtained from embryos and used for PCR to determine
the genotype of each embryo. PCR analysis revealed that
knockout embryos were present at near-Mendelian ratios at
10 dpc but not at 14 dpc. These experiments demonstrated
that most knockout embryos died between 12 dpc and 13
dpc (Fig. 1B).
Examination of 8- to 11-dpc embryos demonstrated that
14-3-3	/	 embryos exhibited signs of developmental arrest,
with smaller deciduae in many cases, similar to heterozygous
TABLE 1. Echocardiographic analysis of wild-type and 14-3-3/	 micea
Genotype (nb) HR (min	1) LVIDd (mm) (LVIDs) (mm) LVPWd (mm) IVSd (mm) LVM (mg) BW (g) FS (%)
Wild type (6) 665  46 3.2  0.22 1.32  0.12 0.60  0.07 0.67  0.07 58.2  6.8 22.2  1.1 58.4  2.7
14-3-3/	 (6) 660  11 3.2  0.15 1.12  0.17 0.57  0.10 0.67  0.05 56.0  8.5 21.2  1.5 64.8  5.5
a Twelve-week-old awake mice underwent transthoracic echocardiography. HR, heart rate; LVIDd, left ventricular internal dimension in diastole; LVIDs, left
ventricular internal dimension in systole; LVPWd, left ventricular posterior wall thickness in diastole; IVSd, interventricular septal thickness in diastole; LVM,
calculated left ventricular mass; BW, body weight; FS, fractional shortening.
b n, number of mice studied.
TABLE 2. Invasive analysis of cardiac physiology in wild-type and 14-3-3/	 micea
Genotype (nb) HR (min	1) LVPmax (mm Hg) LVPed (mm Hg) dP/dtmax (mm Hg/s) dP/dtmin (mm Hg/s)
Tau (Weiss)
(ms)
Wild type (5) 534  18 93  12 5.0  0.8 7,092  2,529 	7,644  2,021 8.0  0.8
14-3-3/	 (5) 551  37 94  11 6.0  2.0 6,209  1,283 	7,159  1,606 9.0  1.9
a Twelve-week-old anesthetized mice underwent invasive cardiac catheterization. HR, heart rate; LVPmax, left ventricular peak systolic pressure; LVPed, left
ventricular end-diastolic pressure; dP/dtmax, maximal change in pressure per unit of time; dP/dtmin, minimal change in pressure per unit of time; Tau, calculated index
of diastolic function.
b n, number of mice studied.
1458 LAU ET AL. MOL. CELL. BIOL.
 o
n
 January 10, 2014 by W
ashington University in St. Louis
http://m
cb.asm
.org/
D
ow
nloaded from
 
embryos at earlier stages, especially at 8 dpc (Fig. 1C). Dissec-
tion of deciduae revealed that occasional 14-3-3	/	 embryos
were undergoing resorption at 8 to 11 dpc, while others were
developmentally delayed and hypomorphic (Fig. 1C and D).
Gross inspection and histologic examination of 14-3-3	/	 and
heterozygous embryos at these developmental stages revealed
generalized developmental delay, without specific defects
noted in the cardiovascular system (Fig. 1D and E).
To confirm that 14-3-3	/	 embryos lacked 14-3-3 mRNA,
we performed a quantitative real-time reverse transcription-
PCR analysis of 9-dpc embryos with primers specific for 14-3-
3. This analysis revealed that 14-3-3	/	 embryos contained
minimal, if any, mRNA encoding 14-3-3 (data not shown).
Evaluation of cardiac function in adult 14-3-3/ mice.
Although 14-3-3	/	 mice did not survive embryonic develop-
ment, 14-3-3/	 mice appeared grossly normal at birth and
were fertile. The body weights of 14-3-3/	 mice were similar
to those of wild-type (WT) littermates measured at 6, 8, 10,
and 12 weeks after birth (data not shown). We evaluated
whether 14-3-3 mRNA and protein levels were reduced in
haploinsufficient mice. We found that these mice had an ap-
proximately 50% reduction in 14-3-3 protein in cardiac tissue
samples (data not shown). Reverse transcription-PCR analysis
also showed that there was a reduction of approximately 50%
in 14-3-3 mRNA expression in 14-3-3/	 mice (data not
shown). The mRNA levels for all other 14-3-3 family members,
including 14-3-3, 14-3-3ε, 14-3-3, 14-3-3, 14-3-3, and 14-
3-3, were tested in cardiac tissue obtained from 14-3-3/	
mice. The mRNA levels of these family members were un-
changed in 14-3-3/	 cardiac tissue (data not shown).
We examined cardiac physiology in adult 14-3-3/	 mice to
determine whether knock-down of 14-3-3 protein would sen-
sitize cardiomyocytes to proapoptotic stimuli. Next, we evalu-
ated the basal cardiac structure and function in 12-week-old
14-3-3/	 mice. Echocardiography demonstrated that 14-3-
3/	 mice had normal systolic function and normal cardiac
chamber sizes and mass (Table 1). Morphometric and histo-
logic analyses showed that the left-ventricular-weight-to-body-
weight ratio and cardiomyocyte cell size (measured by cross-
sectional area on left ventricular tissue sections) were similar
between 14-3-3/	 mice and wild-type littermates (data not
shown). Cardiac catheterization of 12-week-old 14-3-3/	
mice showed that the 14-3-3/	 mice hearts had hemody-
namic properties similar to those of wild-type littermates
(Table 2).
Increased apoptosis in cultured adult 14-3-3/ cardiomyo-
cytes. We previously demonstrated that a primary role of mam-
malian 14-3-3 proteins is to prevent cell death by apoptosis (22).
To determine whether reduction of the 14-3-3 protein would
sensitize cardiomyocytes to proapoptotic stimuli, we isolated
and cultured adult cardiomyocytes from 14-3-3/	 and wild-type
10- to 12-week-old littermates and treated the cells with UVC
irradiation (180 J/m2), a well-described stimulus of apoptosis.
14-3-3/	 cardiomyocytes displayed an approximately eightfold
FIG. 2. Increased apoptosis in adult murine cardiomyocytes ob-
tained from 14-3-3/	 mice. A. Adult cardiomyocytes were isolated
from 14-3-3/	 and wild-type 10- to 12-week-old mice and treated
with UVC irradiation (180 J/m2), a well-described stimulus of apop-
tosis. 14-3-3/	 cardiomyocytes displayed an approximately eightfold-
higher rate of apoptosis than wild-type cells in response to UVC
irradiation (6.30%  3.50% for 14-3-3/	 mice versus 0.76% 
0.37% for wild-type mice; P  0.05; see Fig. 4A). B. 14-3-3/	 car-
diomyocytes were also sensitized to H2O2-induced apoptosis. Treat-
ment of cells with 10 M of H2O2 for 12 h caused 14-3-3
/	 cardio-
myocytes to undergo apoptosis at an approximately 3.5-fold-higher
rate than wild-type cardiomyocytes (0.2753%  0.0154% for 14-3-
3/	 mice versus 0.0874%  0.002% for wild-type mice; P 0.05; see
Fig. 4B). arb. units, arbitrary units.
TABLE 3. Echocardiographic analysis of wild-type and 14-3-3/	 mice after myocardial infarctiona,b
Genotype (nc) SWMSI (1 day) EDV (7 days) (mm3) EDVI (7 days) (mg) ESV (7 days) (mm3) EF (7 days)
Wild type (12) 1.40  0.03 70.7  7.2 3.05  0.41 47.3  7.7 38.1  5.4
14-3-3/	 (11) 1.37  0.03 105.1  12.3 3.80  0.40 78.9  11.7 28.3  3.2
a Twelve-week-old awake mice underwent transthoracic echocardiography 1 or 7 days after experimental myocardial infarction by ligation of the left coronary artery.
SWMSI, segmental wall motion score index (an SWMSI value of 1 indicates normal wall thickening, whereas an SWMSI score of 2 indicates cardiac akinesis). EDV,
end diastolic volume; EDVI, end diastolic volume index (end diastolic volume/body weight in mg); ESV, end systolic volume (mm3); EF, ejection fraction.
b P values were as follows: for SWMSI, 0.37; for EDV, 0.022; for EDVI, 0.20; for ESV, 0.03; for EF, 0.14.
c n, number of mice studied.
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FIG. 3. Increased cardiac remodeling after myocardial infarction in 14-3-3/	 mice. A. Kaplan-Meier survival analysis after myocardial
infarction. 14-3-3/	 mice had much higher mortality 7 days following left coronary artery ligation. B. Ventricular free wall rupture occurs in
14-3-3/	 mice following myocardial infarction surgery. Hearts were isolated from mice and viewed with a dissecting microscope. The right panel
depicts a close-up view of the site of rupture (arrow) in the same heart shown in the left panel. C. Histologic analysis of infarct size 7 days after
ligation of the left coronary artery in wild-type and 14-3-3/	 mice. Hearts were isolated, fixed in formalin, embedded in paraffin, sectioned with
a microtome, stained with trichrome, and analyzed by computerized microscopy. D. Quantitative analysis of histological sections described for
panel B. The area of infarction was divided by the total left ventricular area in each section. Ten sections per heart were analyzed. E. Analysis of
cardiomyocyte apoptosis in the infarct border zone by TUNEL. Hearts were isolated 7 days after myocardial infarction, fixed in formalin,
embedded in paraffin, sectioned with a microtome, and analyzed by TUNEL. The infarct border zone was defined as one-quarter circumference
of the left ventricle on either side of the infarct. F. Analysis of caspase-3 activation in ventricular tissue after myocardial infarction. Ventricles were
isolated 7 days after myocardial infarction, minced, and used to obtain protein lysates. Protein lysates were separated by SDS-PAGE and analyzed
by immunoblotting for cleaved caspase-3. Blots were reprobed for total Akt to control for loading.
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higher rate of apoptosis than wild-type cells in response to UVC
irradiation (6.30%  3.50% for 14-3-3/	 mice versus 0.76% 
0.37% for WT mice; P  0.05) (Fig. 2A). We next determined
whether 14-3-3/	 cardiomyocytes were sensitized to additional
factors known to promote apoptosis. Treatment of cells with 10
M of H2O2 for 12 h caused 14-3-3
/	 cardiomyocytes to un-
dergo apoptosis at an approximately 3.5-fold higher rate than
wild-type cardiomyocytes (0.2753%  0.0154% for 14-3-3/	
cardiomyocytes versus 0.0874%  0.002% for the WT; P 0.05)
(Fig. 2B).
Increased pathological remodeling after myocardial infarc-
tion in 14-3-3/mice. Since 14-3-3/	 cardiomyocytes were
sensitized to proapoptotic stimuli, we hypothesized that 14-3-
3/	 mice would exhibit increased pathological cardiac re-
modeling after experimental myocardial infarction surgery. In
response to coronary artery ligation, there is an initial infarc-
tion stage characterized by widespread necrosis and to a lesser
extent apoptosis in the myocardium directly supplied by the
occluded vessel. In the days and weeks after a myocardial
infarction, a chronic phase of ventricular remodeling occurs
that is often maladaptive and that is characterized by persistent
cardiomyocyte apoptosis, thinning of the ventricular wall at the
infarct site, fibrosis, chamber enlargement, and cardiac myo-
cyte hypertrophy (17).
Experimental myocardial infarction was performed on 14-3-
3/	 and wild-type littermates by a surgeon who was blinded
to the genotypes of the mice. Coronary artery anatomy is
variable in mice; therefore, the area of myocardium affected by
coronary artery ligation was quantified in every animal on the
day after surgery. Once a murine coronary artery is ligated,
myocardium supplied by that artery exhibits reduced or absent
contractile function. Quantitative two-dimensional echocardi-
ography was performed 1 day after surgery to determine the
segmental wall motion score index (SWMSI), and this demon-
strated that the area of myocardium directly supplied by the
ligated coronary arteries was nearly identical in wild-type and
14-3-3/	 mice. An SWMSI value of 1 indicates normal wall
thickening, whereas an SWMSI score of 2 indicates absent
ventricular wall motion (akinesis). The initial SWMSI was 1.40 
0.03 for wild-type mice and was 1.37  0.03 for 14-3-3/	 mice
(P value not significant) (Table 3).
Although all animals survived for the first 24 h after experi-
mental myocardial infarction surgery, the mortality rate was
higher for 14-3-3/	 mice over the following 6 days. Eleven out
FIG. 3—Continued.
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of fifteen wild-type animals (73%) survived for at least 7 days after
myocardial infarction surgery (Fig. 3A). In contrast, only 7 out of
17 14-3-3/	 mice (41%) were alive 7 days after surgery (Fig.
3A). This difference in survival was statistically significant by log-
rank test (2  4.8236; P  0.05). Analysis of deceased mice by
necropsy revealed that mice uniformly died from ventricular free
wall rupture (Fig. 3B). To exclude the possibility that 14-3-3/	
mice were uniquely sensitive to anesthesia or thoracotomy, sham
operations were performed, and all 14-3-3/	 mice tolerated the
sham procedure and survived for 7 days.
To evaluate ventricular remodeling after myocardial infarc-
tion, echocardiography was performed 1 week after myocardial
infarction surgery with surviving mice (Table 3). 14-3-3/	
mice exhibited marked left ventricular dilatation compared to
wild-type mice. End systolic volume and end diastolic volume
were significantly higher in 14-3-3/	 mice than in wild-type
animals (P  0.05 for both ESV and EDV) (Table 3). The left
ventricular ejection fraction was reduced in 14-3-3/	 heart,
but this reduction was not statistically significant (Table 3).
To further evaluate the remodeling process in ventricular
tissue, the size of infarcted myocardium was evaluated 7 days
after left coronary artery ligation. The size of the myocardial
FIG. 3—Continued.
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infarction at this time point reflects both the initial infarct size
and infarct expansion that occurs with pathological remodel-
ing. Hearts were isolated 7 days after left coronary artery
ligation, fixed in 10% formalin, embedded in paraffin, and
sectioned with a microtome. Histological examination of
trichrome-stained ventricular tissue sections revealed that the
area of myocardial infarction was significantly greater in 14-3-
3/	 mice than in wild-type animals (48.0%  3.1% versus
31.9%  2.3%; P  0.005) (Fig. 3C and D).
Apoptosis in the infarct border zones is a hallmark of patho-
logical ventricular remodeling after myocardial infarction.
Evaluation of apoptosis in the infarct border zones by TUNEL
revealed that there were significantly more TUNEL-positive
nuclei in 14-3-3/	 than in wild-type ventricular tissue (Fig.
3E). In a separate set of experiments, left ventricular tissue
obtained 7 days after myocardial infarction surgery was used to
generate protein lysates. Immunoblotting with an anti-cleaved
caspase-3 antibody showed greatly increased cleaved caspase-3
protein levels in 14-3-3/	 ventricular tissue than in wild-type
ventricular tissue (Fig. 3F).
Altered signal transduction in 14-3-3/ cardiac tissue.
We previously demonstrated that global inhibition of 14-3-3
proteins in cardiac tissue by overexpression of a dominant-
negative form of 14-3-3 resulted in increased ASK1, p38
MAPK, and JNK activity (22). To determine whether selective
knock-down of 14-3-3/	 would also result in increased car-
diac ASK1 signaling, a series of signal transduction experi-
ments was performed.
Activation of ASK1 was evaluated by immunoblotting with
an antibody that recognizes the inactive (Ser-84-phosphory-
lated) form of this protein, and this revealed that ASK1 acti-
vation was higher in 14-3-3/	 ventricular tissue (Fig. 4).
Activation of JNK and p38 MAPK was evaluated by immuno-
blotting with antibodies that specifically recognize the active
(phosphorylated) forms of these proteins. Analysis of ventric-
ular protein lysates obtained from 12-week-old mice revealed
FIG. 4. Analysis of signaling protein activity in 14-3-3/	 mice. Protein lysates were generated from ventricular tissue obtained from 10- to
12-week-old wild-type and 14-3-3/	 mice. Lysates were separated by SDS-PAGE and analyzed by immunoblotting with primary antibodies
directed against phosphorylated p38, phosphorylated JNK, total JNK, phosphorylated ERK MAPK, total ERK MAPK, phosphorylated ASK1,
phosphorylated Akt, and total Akt. Immunoblots were quantified by the computerized densitometry program Image J (NIH). Results were
combined from three separate experiments (n  11 for the wild type; n  11 for 14-3-3/	 mice). arb. units, arbitrary units.
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that there was increased activation of JNK and p38 MAPK in
14-3-3/	 tissue compared to wild-type tissue (Fig. 4). In
contrast, ERK MAPK activation was reduced in 14-3-3/	
ventricular tissue compared to wild-type tissue (Fig. 4). Results
shown in Fig. 4 were combined from three separate experi-
ments (n  11 for the wild type; n  11 for 14-3-3/	 mice).
Inhibition of p38 MAPK improved survival for 14-3-3/
mice after myocardial infarction. We previously demonstrated
that pharmacologic or genetic inhibition of p38 MAPK activ-
ity in heart tissue ameliorated the proapoptotic phenotype
observed in DN-14-3-3 transgenic mice (26). To determine
whether the increased apoptosis observed in 14-3-3/	 cardio-
myocytes was due to increased p38 MAPK activity, we treated
wild-type and 14-3-3/	 mice with SB202190, a p38 and -
inhibitor, by intraperitoneal injection (5 mg/kg/day). Left cor-
onary artery ligation was performed after 3 days of SB202190
administration. Mice were monitored for survival until the
eighth day of SB202190 treatment.
To confirm that SB202190 effectively blocked p38 MAPK
activity, cardiac protein lysates were generated after 8 days of
treatment. Cardiac protein lysates were analyzed by anti-phos-
pho-p38 MAPK and by anti-phospho-activity transcription fac-
tor 2 (ATF2) immunoblotting. ATF2 is a well-defined sub-
strate for p38 MAPK. Phosphorylation of p38 MAPK and
ATF2 was markedly reduced in the myocardium of SB202190-
treated 14-3-3/	 mice compared to results with vehicle-
treated 14-3-3/	 mice (Fig. 5A).
Vehicle-treated 14-3-3/	 mice had a survival rate of only
47% after myocardial infarction (8/17 animals survived) (Fig.
5B). In contrast, injection of 14-3-3/	 mice with SB202190
increased the survival rate to 76% (13/17 survived), which is
similar to the rate observed with wild-type mice after myocar-
dial infarction. This difference in survival was statistically sig-
nificant by log-rank test (2  4.175; P  0.05). Therefore,
pharmacological inhibition of p38 MAPK reversed the en-
hanced mortality of 14-3-3/	 mice after myocardial infarc-
tion.
DISCUSSION
The 14-3-3 family regulates many aspects of cell physiology,
but the antiapoptotic effect of these proteins may be of primary
import. Previous work demonstrated that global inhibition of
14-3-3 action by use of peptide inhibitors or dominant-negative
mutant forms of 14-3-3 proteins sensitized cultured cells and
cardiac tissue to proapoptotic stimuli (11, 22). However, a
specific requirement for a particular family member was not
established. In the current work, the 14-3-3 genomic locus was
disrupted and mice haploinsufficient for 14-3-3 were exam-
ined. 14-3-3	/	 mice did not survive embryonic development,
and all embryos died by 14 dpc. 14-3-3	/	 embryos were
hypomorphic and exhibited developmental delay compared to
heterozygous embryos at 8 to 11 dpc. In contrast, haploinsuf-
ficient mice appeared normal at birth, but cultured cardiomyo-
cytes from haploinsufficient mice were sensitized to proapop-
totic stimuli. Furthermore, 14-3-3/	 mice developed larger
myocardial infarctions with exaggerated pathological cardiac
remodeling after occlusion of the left coronary artery. These
results demonstrate that 14-3-3 plays an important antiapop-
totic role in cardiac tissue. The current work is the first to show
a specific requirement for an individual 14-3-3 family member
in cell survival.
The mechanisms underlying the antiapoptotic effect of 14-
3-3 in cardiac tissue are not completely understood, but our
data suggest that the ASK1-p38 MAPK signaling pathway is
involved in this biologic effect. The protein kinase ASK1 is
thought to be a powerful mediator of apoptosis in cardiac
tissue in response to various types of external stress. In 14-3-3
cardiac tissue, ASK1 and its downstream effectors p38 MAPK
and JNK exhibited increased activation in comparison to re-
sults with wild-type cardiac tissue. Pharmacologic inhibition of
p38 MAPK in 14-3-3/	 mice ameliorated the proapoptotic
phenotype observed after experimental myocardial infarction.
Experiments are ongoing to determine whether direct inhibi-
tion of ASK1 or JNK activity can also reverse the cardiac
phenotype in 14-3-3/	 mice.
Many studies have shown that pharmacologic or genetic
inhibition of p38/ MAPK reduced cardiomyocyte apoptosis
in response to provocative stimuli in rodents (8, 10, 16, 17, 19,
26). Paradoxically, cardiac-specific ablation of p38 MAPK in
mice also promoted cardiomyocyte apoptosis in response to
pressure overload by transverse aortic constriction (15). One
interpretation of these data is that low-level activity of p38
MAPK promotes cardiomyocyte survival, perhaps indirectly
through expression of additional proteins, but that activation
above a particular threshold is proapoptotic. Given that there
is evidence of low-level p38 MAPK activation in apparently
healthy cardiomyocytes, this may be a reasonable hypothesis.
The mechanisms by which p38 MAPK promotes cardiomyo-
cyte apoptosis may include the ability of p38 MAPK to induce
the deamidation of BCL-X(L) (17). In addition, p38 MAPK
enhances the phosphorylation and activation of the proapop-
totic transcription factor p53 (2).
14-3-3 likely inhibits apoptosis through a variety of mech-
anisms in addition to its ability to antagonize ASK1 signaling,
and the ability of 14-3-3 to sequester BAD and FOXO family
members may also be important for this effect. Previous work
demonstrated that the treatment of rat neonatal cardiomyo-
cytes with phenylephrine promoted the phosphorylation and
inactivation of BAD via binding to 14-3-3 (21). It is likely that
FIG. 5. Reduced mortality after myocardial infarction in response to p38 MAPK inhibition. SB202190, a p38 and - inhibitor, was injected
intraperitoneally into wild-type and 14-3-3/	 animals (5 mg/kg/day). A. Reduced cardiac p38 MAPK activity in 14-3-3/	 mice injected with
SB202190. Protein lysates were generated from hearts taken from mice injected daily with SB202190 (SB) or vehicle for 8 days. Cardiac lysates
were analyzed by anti-phospho-p38 MAPK and anti-phospho-ATF2 immunoblotting. Anti-total-ERK MAPK immunoblotting was performed to
control for protein loading. B. SB202190 treatment increases survival for 14-3-3/	 mice after MI. Left coronary artery ligation was performed
after 3 days of SB202190 administration. The increased survival of 14-3-3/	 mice injected with SB202190 compared to mice injected with vehicle
was statistically significant by the log-rank test (76% versus 46%; P  0.046).
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14-3-3 modulates the activity of multiple enzymatic cascades
to ensure the survival of cardiomyocytes.
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